Ignite Creation Date:
2024-05-05 @ 11:49 AM
Last Modification Date:
2024-10-26 @ 9:14 AM
Study NCT ID:
NCT00143117
Status:
COMPLETED
Last Update Posted:
2012-11-07
First Post:
2005-08-30
Brief Title:
Assessment of Efficacy and Safety of UK-390957 in Men With Premature Ejaculation
Sponsor:
Pfizer
Organization:
Pfizer
Study Overview
Official Title:
A Phase 2b Multi-Center Double-Blind Placebo-Controlled Parallel Group Dose Response Study to Assess the Efficacy and Safety of Oral UK-390957 in Men With Premature Ejaculation
Status:
COMPLETED
Status Verified Date:
2012-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To determine whether UK-390957 is an effective and safe treatment for premature ejaculation
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None